Dr. Nosisa Sipambo

Nosisa Sipambo is a researcher in paediatric and adolescent HIV, closely associated with South African cohorts and the International epidemiology Databases to Evaluate AIDS consortium. Her work centres on optimizing antiretroviral therapy in children and adolescents in low- and middle-income settings, with a strong emphasis on translating cohort data into policy and clinical guidance.

Her publications examine immune suppression at ART initiation, CD4 monitoring trends, and outcomes among vulnerable groups including infants, pregnant adolescents, and females of reproductive age. She has contributed to evidence on abacavir safety in neonates, disparities in dolutegravir uptake, and transitions to newer regimens, as well as the impact of COVID-19 on HIV service delivery.

Sipambo’s research highlights persistent gaps in immune monitoring, retention in care, and equitable access to optimal treatment. By integrating large observational cohorts with guideline development efforts, her work informs regional and global HIV policies aimed at improving survival and long-term outcomes for children and adolescents living with HIV.